Riskpilot← Back to searchSign inGet full accessUnimedic Pharma Holding AB
ABActiveOrg 5562709740Storjordenvägen 2Manufacture of pharmaceutical preparations · NACE 2120Est. 19860 employees
Revenue 2024
SEK 3,5M
+29% vs 2023
EBITDA margin
-32.1%
-106% vs 2023
Equity ratio
0.7%
Financial strength
Net profit 2024
SEK -148K
-134% vs 2023
| Revenue | SEK 3,5M | +29% |
| EBITDA | SEK -1,1M | -106% |
| Net profit | SEK -148K | -134% |
| Total assets | SEK 82,1M | +1% |
| Equity | SEK 606K | -20% |
| Employees | 0 | — |
Legal name
Unimedic Pharma Holding AB
Org number
5562709740
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
13 januari 1986
Share capital
SEK 300 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med Frödin, Johan Emil Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att köpa och förvalta bolag inom läkemedelsbranschen.
Address
Storjordenvägen 2
Phone
+4697016565
Email
info@unimedicpharma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 832 | 3 720 | 3 993 | 2 714 | 3 500 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −161 | −524 | −1 553 | −547 | −1 125 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −161 | −524 | −1 553 | −547 | −1 125 |
| Net financials | −1 391 | −1 301 | −1 580 | −3 894 | −4 019 |
| Profit before tax | −434 | −1 301 | −133 | 1 559 | 856 |
| Tax | −0 | −62 | −298 | −1 123 | −1 004 |
| Net profit | −434 | −1 363 | −431 | 436 | −148 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 75 583 | 76 177 | 81 243 | 81 375 | 82 135 |
| Equity | 862 | 499 | 318 | 754 | 606 |
| Long-term debt | 68 246 | 63 216 | 73 333 | 74 573 | 75 934 |
| Short-term debt | 6 475 | 12 462 | 7 592 | 6 048 | 5 595 |
| Total debt | 74 721 | 75 678 | 80 925 | 80 621 | 81 529 |
EBITDA margin
-32.1%
This company
15.8%
Market median
-303% vs market
20202024
Equity ratio
0.7%
This company
38.2%
Market median
-98% vs market
20202024
Return on equity
-24.4%
This company
18.4%
Market median
-233% vs market
20202024
Net profit margin
-4.2%
This company
8.1%
Market median
-152% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
134.54×
This company
0.62×
Market median
-21600% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
AV Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2020 | |
| Board of Directors | 2022 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Chairman | 2020 – 2020 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MedCap AB (publ)
Unimedic Pharma Holding AB Board members of Unimedic Pharma Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Emil Frödin | Chief Executive Officer | 0 companies |
| Anna Valborg Elisabeth Linton | Chief Executive Officer | 0 companies |
| Kristina Madelene Ekblad | Deputy Board Member | 0 companies |
| Anders Dahlberg | Board of Directors | 0 companies |
| Per Anders Larnholt | Chairman | 0 companies |
| Snickar Karl Johan Tobieson | Chairman | 0 companies |
| Nils Gunnar Gårdemyr | Board of Directors | 0 companies |
| Lars Åke Gunnar Hallman | Board of Directors | 0 companies |
| Dan Mårten Österlund | Board of Directors | 0 companies |